Tue.Jul 16, 2024

article thumbnail

J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses

Fierce Pharma

Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act. | Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act.

290
290
article thumbnail

CCC Pioneers Collective Licensing Solution for Content Usage in Internal AI Systems

Copyright Clearance Center

July 16, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced the availability of artificial intelligence (AI) re-use rights within its Annual Copyright License s (ACL), an enterprise-wide content licensing solution offering rights from millions of works to businesses that subscribe.

Education 134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Johnson & Johnson proposes $505M settlement with bankrupt talc miners

Fierce Pharma

As Johnson & Johnson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds | As Johnson & Johson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds of millions of dollars to settle a longstanding dispute with a clutch of suppliers.

272
272
article thumbnail

Tau-Focused Asceneuron Adds $100M as Oral Alzheimer’s Drug Advances to Phase 2 Trial

MedCity News

Novo Holdings led Asceneuron’s $100 million Series C financing. The Merck Serono spinout’s lead program is an oral small molecule designed to prevent aggregation of tau protein in neurodegenerative disorders. The post Tau-Focused Asceneuron Adds $100M as Oral Alzheimer’s Drug Advances to Phase 2 Trial appeared first on MedCity News.

Leads 113
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Sobi, angling to become a major hematology player, touts momentum across several brands

Fierce Pharma

With several launches underway and partnerships driving sales growth, Sobi is gaining momentum in its quest to become a force in hematology. | The Swedish drugmaker reported 13% sales growth in its hematology portfolio, which includes brands such as Doptelet, Vonjo and Apellis-partnered Empaveli (or Aspaveli in Europe, which is one of Sobi's territories).

Sales 252
article thumbnail

What Does It Take to Move an Entire Hospital in 1 Day? Intermountain Health Is About to Find Out

MedCity News

For the past two years, Intermountain Health has been planning to move its hospital in the Denver suburb of Wheat Ridge, Colorado about three and a half miles away to a new and updated facility. The health system is planning to complete the move in one day, using about 20 ambulances to move an estimated 180 patients. The post What Does It Take to Move an Entire Hospital in 1 Day?

Patients 108

More Trending

article thumbnail

CCC Launches Collective Licensing for AI

Copyright Clearance Center

Copyright Clearance Center has launched a collective licensing solution for the internal use of copyrighted materials in artificial intelligence systems, with the aim of providing streamlined, legal means to use content and compensate creators.

98
article thumbnail

Seven Starling Secures $10.9M To Improve Access to Women’s Mental Health

MedCity News

Seven Starling’s Series A funding round was led by RH Capital and included participation from Pear VC, Expa and Magnify Ventures. In total, the company has raised $14.3 million. The post Seven Starling Secures $10.9M To Improve Access to Women’s Mental Health appeared first on MedCity News.

103
103
article thumbnail

Has pharma emerged from the ‘age of uncertainty’?

PharmaVoice

An industry reeling from a precarious market is showing signs of stabilizing as the future becomes a little less cloudy, an Evaluate report suggests.

Pharma 106
article thumbnail

The Triad of Inclusivity, Innovation, and Scalability: Imperatives for Today’s Clinical Trial Teams

MedCity News

As the clinical trial landscape evolves, prioritizing inclusion, innovation, and scalability is essential for accelerating the development of safe and effective treatments that truly meet the needs of diverse patient populations. The post The Triad of Inclusivity, Innovation, and Scalability: Imperatives for Today’s Clinical Trial Teams appeared first on MedCity News.

Patients 104
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

GLP-1 bonanza spurs big investment at CDMO CordenPharma

pharmaphorum

CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.The three-year plan revolves around parallel programmes in the US and Europe that will include new builds and upgrades and expansion to its existing facilities, according to the German contract development and manufacturing organisation (CDMO).

article thumbnail

The Consent Conundrum Pediatricians Face

MedCity News

As the consent landscape continues to evolve, pediatricians are tasked with striking a careful balance – respecting the autonomy of their teenage patients while still operating within the guardrails of state regulations and parental authority. The post The Consent Conundrum Pediatricians Face appeared first on MedCity News.

article thumbnail

Novo leads $100m financing for Alzheimer's player Asceneuron

pharmaphorum

Novo Holdings leads $100m financing for Swiss biotech Asceneuron, which is developing an oral tau therapy for Alzheimer's disease

Leads 104
article thumbnail

AstraZeneca completes Amolyt Pharma acquisition

Pharmaceutical Technology

AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases.

Pharma 103
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

NHS on course to use digital tech to diagnose ADHD

pharmaphorum

A digital diagnostic for ADHD called QbTest should be used by the NHS as an add-on to standard assessment, says new NICE guidance

100
100
article thumbnail

Kyverna wins RMAT designation for stiff-person syndrome for cell therapy candidate

Pharmaceutical Technology

Kyverna’s CEO Peter Maag said the biotech is “eager to start generating data” from a Phase II trial.

98
article thumbnail

Study finds Parkinson’s disease SLT more effective than one used in NHS

PharmaTimes

The progressive neurodegenerative condition affects around 153,000 people in the UK

103
103
article thumbnail

German CDMO outlays $980m on GLP-1 manufacturing expansion

Pharmaceutical Technology

As the EU anticipates GLP-1RA shortages throughout 2024, Corden Pharma has pledged $980m to increase manufacturing capacity.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Artiva announces terms for its second IPO attempt

pharmaphorum

Natural killer cell therapy specialist Artiva Biotherapeutics has another go at an IPO, hoping to raise up to $135m

91
article thumbnail

KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer

PharmaTimes

Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK

Leads 86
article thumbnail

FDA’s lab developed test rule could be first check on agency’s power post-Chevron

PharmaVoice

The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.

59
article thumbnail

Sell the Soul, Not the Solution

Contrarian Sales Techniques

Alex was a medical sales rep, a purveyor of hope in sleekly designed packaging. His product, a revolutionary new stent, was a marvel of engineering, a tiny titanium miracle worker. But Alex knew that dazzling doctors with technical specifications was like trying to seduce a fish with a fishing rod. What really sold was understanding the unspoken needs of the cardiac surgeon, the late-night anxieties in the emergency room, the weight of life and death hanging in the balance.

Doctors 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

PDA BioManufacturing Conference 2024: Sept. 24 and 25, 2024

PharmaTech

The event will explore new technologies such as AI, digital twins, development approaches, CMC strategies, and regulatory frameworks, supporting rapid access to vaccines and biotherapeutics.

52
article thumbnail

Mastering commercial ecosystems in pharma

Vodori

Unveiling the complexity of pharma commercial ecosystems The pharmaceutical industry is a complex and dynamic field where innovation, regulation, and market needs intersect. At the heart of this industry lies the commercial ecosystem, a multifaceted network of internal and external stakeholders, processes , and technologies working in unison to bring therapeutic solutions from conception to the patient.

Pharma 52
article thumbnail

Innovative chromatography method shows sustainability potential

European Pharmaceutical Review

A study has reported the first application of twin-column recycling chromatography to a cannabidiol (CBD)-rich cannabis extract for separation and the final depletion of tetrahydrocannabinol (THC) using a sustainable solvent. The twin-column recycling approach was applied using pure ethanol (EtOH) as a green solvent as the mobile phase. Notably, psychoactive THC was fully removed from a Cannabis extract rich in CBD, under continuous conditions, the paper reported.

article thumbnail

The burden of diabetic vision loss in the West

pharmaphorum

Vision loss associated with diabetes is one of the more prevalent and growing healthcare burdens in the Western world. In today’s podcast, web editor Nicole Raleigh welcomes Dr Catherine Beech, CEO of Exonate, for a discussion on retinal vascular disease and a potential eye drop treatment for diabetic retinopathy and diabetic macular oedema, instead of invasive injections into the eye.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Broader Implications for the Drug Discovery Field

PharmExec

In this part of his Pharmaceutical Executive video interview, Fabrice Chouraqui, CEO of Cellarity, speaks about the broader implications of Cellarity's approach for the drug discovery field.

article thumbnail

A Comprehensive Review on plant Sida cordifolia L. including its phyto-chemical status and pharmacological properties

Pharmatutor

A Comprehensive Review on plant Sida cordifolia L. including its phyto-chemical status and pharmacological properties admin Tue, 07/16/2024 - 15:09 ABOUT AUTHOR Devansh Mehta 1* Author : M.Pharmacy in Pharmacology, M.B.A. in Pharmaceutical Marketing and Hospital Administration, B.Pharmacy. Founding Medical Writing Director, TRM Writer’s LLP Address: Flat No. 301, Third Floor, Eden Garden Housing Complex, Bypass Road, Modipuram, Meerut.

article thumbnail

Pharma Pulse 7/16/24: Universities Don’t Want AI Research to Leave Them Behind, The AI Revolution Comes to Pharmacy & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 96
article thumbnail

PDA/FDA Joint Regulatory Conference 2024: Sept. 9–11, 2024

PharmaTech

The co-sponsored event includes sessions, interactive discussions, regulatory updates, and case studies regarding the current good manufacturing practice requirements.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A